WILMINGTON, N.C.--(BUSINESS WIRE)--Apr 28, 2021-- PPD, Inc. (Nasdaq: PPD ), a leading global contract research organization, is expanding its Athlone, Ireland, GMP (good manufacturing practices) laboratory, significantly increasing the size of its current facility and adding cell and gene therapy testing to the operationâs portfolio of services. The expansion enhances PPDâs ability to deliver global scientific and technical expertise to meet growing customer demand in Europe, the Middle East and Africa, and the Asia-Pacific region. By offering these services at its Athlone operation, PPD can provide clients in these locations with the same services already available in the U.S. through its Middleton, Wisconsin, GMP lab.